BSE LIMITED | Notice No. | 20230116-16 | Notice Date | 16 Jan 2023 | |||
| Category | Company related | Segment | Equity | |||
| Subject | Listing of new securities of Sun Pharmaceutical Industries Ltd. | |||||
| Content |
Trading Members of the Exchange are hereby informed that the under mentioned new securities of Sun Pharmaceutical Industries Ltd. (Scrip Code: 524715) are listed and permitted to trade in with effect from Tuesday, January 17, 2023.<_o3a_p>
<_o3a_p><_o3a_p>
Securities<_o3a_p> | *330 Equity Shares of Re. 1/- each (pursuant to Bonus) kept in abeyance.<_o3a_p> <_o3a_p><_o3a_p> | |
ISIN<_o3a_p> | INE044A01036<_o3a_p> | |
| Distinctive Numbers<_o3a_p> | 220<_o3a_p> <_o3a_p><_o3a_p> <_o3a_p> | 1035555326 to 1035555545<_o3a_p> |
110<_o3a_p> | 1035555586 to 1035555695<_o3a_p> | |
| <_o3a_p> <_o3a_p> |
<_o3a_p>
*Please note that the entire 330 bonus equity shares are issued in physical form.<_o3a_p>
<_o3a_p><_o3a_p>Sabah Vaze<_o3a_p>
Senior Manager<_o3a_p>
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
BSE Ltd. published this content on 16 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 January 2023 12:09:07 UTC.
